Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

IGILUC 2019

18 - 19 Apr 2019

The JW Marriott Hotel, Cairo, Egypt

Pre-operative radiation for pancreatic cancer

Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA

Pre-operative radiation for pancreatic cancer ( Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA )

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA

Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )

Local treatment in oligometastatic prostate cancer: Radiotherapy

Prof Mach Roach III - University of California, San Francisco, USA

Local treatment in oligometastatic prostate cancer: Radiotherapy ( Prof Mach Roach III - University of California, San Francisco, USA )

SBRT photons, protons or carbon for prostate cancer: How good is the data?

Prof Mach Roach III - University of California, San Francisco, USA

SBRT photons, protons or carbon for prostate cancer: How good is the data? ( Prof Mach Roach III - University of California, San Francisco, USA )

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Colorectal cancer in the young: What do we know and what can we do?

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Colorectal cancer in the young: What do we know and what can we do? ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures

Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures ( Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK )

Beyond second-line therapy: New hope for mCRC patients in Egypt

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Beyond second-line therapy: New hope for mCRC patients in Egypt ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Multi-target kinase inhibitors: From data to practice

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Multi-target kinase inhibitors: From data to practice ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Using genetic testing to tailor chemotherapy

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Using genetic testing to tailor chemotherapy ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Differences in hormone therapy for patients with advanced metastatic prostate cancer

Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany

Differences in hormone therapy for patients with advanced metastatic prostate cancer ( Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany )

Role of interventional oncology for immunology treatment

Prof Thierry De Baere - Institut Gustave Roussy, Paris, France

Role of interventional oncology for immunology treatment ( Prof Thierry De Baere - Institut Gustave Roussy, Paris, France )

Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour)

Prof Thierry De Baere - Institut Gustave Roussy, Paris, France

Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour) ( Prof Thierry De Baere - Institut Gustave Roussy, Paris, France )

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France

State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )

Emerging role of radioembolization for hepatocellular carcinoma

Prof Riad Salem - Northwestern University, Chicago, USA

Emerging role of radioembolization for hepatocellular carcinoma ( Prof Riad Salem - Northwestern University, Chicago, USA )

EAU prostate cancer guidelines 2019: What changed and why?

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France

EAU prostate cancer guidelines 2019: What changed and why? ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )

Neoadjuvant treatment before radical prostatectomy: Current situation

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France

Neoadjuvant treatment before radical prostatectomy: Current situation ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )

Principle and technique for radiofrequency ablation of benign thyroid nodules

Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates

Principle and technique for radiofrequency ablation of benign thyroid nodules ( Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates )

Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Surgical management of pancreatic cancer

Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia

Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Advanced gastric cancer: What do we know and what we must know?

Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA

Advanced gastric cancer: What do we know and what we must know? ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )

Novel approaches and future strategies in management of upper GI tumours

Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA

Novel approaches and future strategies in management of upper GI tumours ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )

Quality of life and local treatment of oligometastatic prostate cancer

Prof Claude Abbou - Clinique de l'Alma, Paris, France

Quality of life and local treatment of oligometastatic prostate cancer ( Prof Claude Abbou - Clinique de l'Alma, Paris, France )

Challenges in the treatment of upper urinary tract tumours

Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK

Challenges in the treatment of upper urinary tract tumours ( Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK )

More from ecancer